BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang HY, Qi MM, Zhang K, Zhu YZ, Zhang J. Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment. World J Gastroenterol 2025; 31(34): 108617 [PMID: 40937451 DOI: 10.3748/wjg.v31.i34.108617]
URL: https://www.wjgnet.com/1007-9327/full/v31/i34/108617.htm
Number Citing Articles
1
Shan-Shan Xie, Zhi-Gang Liu. Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosisWorld Journal of Gastroenterology 2025; 31(46): 113298 doi: 10.3748/wjg.v31.i46.113298
2
Jun Xu, Ying Qian, Jun-Min Wang, Xing-Li Wu, Yi-Yuan Zheng. Levodopa: A novel therapeutic prospect for liver diseaseWorld Journal of Hepatology 2026; 18(2): 115563 doi: 10.4254/wjh.v18.i2.115563